CRP and neoplasm: The patient subgroup with positive levels of both SCC-Ag and CRP demonstrated a profoundly significant association with clinical stage (P<0.001), clinical tumor status (P<0.001) and nodal status (P<0.001) compared to other patient groups (Table 3).